Dr. Wrangle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-937-6110- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
Emory University School of MedicineResidency, Internal Medicine, 2005 - 2008
Tulane University School of MedicineClass of 2005
Certifications & Licensure
SC State Medical License 2014 - 2025
MD State Medical License 2008 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer Start of enrollment: 2006 Aug 01
- Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Publications & Presentations
PubMed
- 1 citationsNovel Collaborations Across Training Programs to Support Mentoring in Sex Differences Research.Aimee L McRae-Clark, Kathleen T Brady, Diana Lee-Chavarria, Jacqueline F McGinty, Kevin M Gray, John Wrangle, Marc Chimowitz> ;Journal of Women's Health. 2023 Aug 1
- 5 citationsSafety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Danny Nguyen, Victor Ho-Fun Lee, James Chih-Hsin Yang, Vamsidhar Velcheti, John M Wrangle, Ma...> ;Journal of Clinical Oncology. 2023 Sep 10
- 2 citationsAssociation of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors.Ashley V Howell, Mulugeta Gebregziabher, Bruce H Thiers, Evan M Graboyes, Chrystal M Paulos, John M Wrangle, Kelly J Hunt, Kristin Wallace> ;Journal of Geriatric Oncology. 2022 Sep 1
- Join now to see all
Press Mentions
FDA, SC Experts Say COVID Boosters Will Help Some Patients — but Not Everyone Gets One YetAugust 13th, 2021- COVID-19: The State of the ScienceMay 19th, 2021
- ImmunityBio Announces Positive Phase 2 Results Showing That Anktiva Restores the Activity of Checkpoint Inhibitors in Patients Who Have Relapsed Checkpoint Immunotherapy in Non-Small Cell Lung CancerJanuary 28th, 2021
- Join now to see all
Hospital Affiliations
MUSC Health University Medical CenterCharleston, South Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
